| Patents for C12N 15 - Mutation or genetic engineering; Dna or rna concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor (402,210) |
|---|
| 01/05/2012 | CA2801808A1 Novel microrna precursor and use thereof in regulation of target gene expression |
| 01/05/2012 | CA2708846A1 Method and kit for the collection, preservation and transport of nucleic acids from saliva samples |
| 01/04/2012 | EP2402760A1 Method for determining protein solubility |
| 01/04/2012 | EP2402754A2 Unstructured recombinant polymers and uses thereof |
| 01/04/2012 | EP2402463A2 Nucleic acid molecules and collections thereof, their application and identification |
| 01/04/2012 | EP2402459A2 Genes involved in Asymmetric Cell Division |
| 01/04/2012 | EP2402452A1 Fermentive production of four carbon alcohols |
| 01/04/2012 | EP2402451A2 Method for stabilizing an DNA insert in a recombinant vaccinia vector |
| 01/04/2012 | EP2402450A1 Methods to obtain recombinant proteins with decreased LacdiNac structures |
| 01/04/2012 | EP2402449A2 An animal model and a method for producing an animal model |
| 01/04/2012 | EP2402448A2 Production of polyunsaturated fatty acids in oleaginous yeasts |
| 01/04/2012 | EP2402447A1 Endogenous retrovirus and proteins encoded by env gene as a target for cancer treatment |
| 01/04/2012 | EP2402446A1 Gene involved in the development of the seed |
| 01/04/2012 | EP2402445A1 Recombinant vaccines against caligid copepods (sea lice) and antigen sequences thereof |
| 01/04/2012 | EP2402444A1 Modulators of body weight, corresponding nucleic acids and proteins, and diagnostic and therapeutic uses thereof |
| 01/04/2012 | EP2402443A2 Therapeutic uses of inhibitors of rtp801 |
| 01/04/2012 | EP2402442A2 Immunostimulatory properties of oligonucleotide-based compounds comprising modified immunostimulatory dinucleotides |
| 01/04/2012 | EP2402441A1 Compositions and methods for control of insect infestations in plants |
| 01/04/2012 | EP2402440A1 -glucan-deficient gene in barley, synthetic gene, and use of same |
| 01/04/2012 | EP2402439A1 Immunization method using cancer cell |
| 01/04/2012 | EP2402438A2 Protease screening methods and proteases identified thereby |
| 01/04/2012 | EP2402437A2 Protease screening methods and proteases identified thereby |
| 01/04/2012 | EP2402435A2 Targeting PAX2 for the induction of DEFB1-mediated tumor immunity and cancer therapy |
| 01/04/2012 | EP2402429A1 Equol-producing bacterium and use thereof |
| 01/04/2012 | EP2402373A2 Anti-EphB4 Antibodies and Methods Using Same |
| 01/04/2012 | EP2402372A2 Therapeutic agent |
| 01/04/2012 | EP2402359A1 Recombinant protective protein from streptococcus pneumoniae |
| 01/04/2012 | EP2402038A1 Telomerase reverse transcriptase for protection against ageing |
| 01/04/2012 | EP2402033A1 Cell adhesion inhibitor and use thereof |
| 01/04/2012 | EP2402031A1 Immunologic adjuvant composition and use thereof |
| 01/04/2012 | EP2402016A1 Aptamers that inhibit interaction between antibody and 1st or 2nd extracellular loop of human beta-1-adrenergic receptor |
| 01/04/2012 | EP2401408A2 Ovarian cancer methylome |
| 01/04/2012 | EP2401404A2 Free circulating dna bio-markers and their applications |
| 01/04/2012 | EP2401397A2 Protein targets in disease |
| 01/04/2012 | EP2401385A1 Methods for increasing starch content in plant cobs |
| 01/04/2012 | EP2401384A1 Reverse genetics using non-endogenous pol i promoters |
| 01/04/2012 | EP2401383A1 Methods for selecting eukaryotic cells expressing a heterologous protein |
| 01/04/2012 | EP2401382A1 HYPER IgE ANIMAL MODEL WITH ENHANCED IMMUNOGLOBULIN HEAVY CHAIN CLASS SWITCHING TO C |
| 01/04/2012 | EP2401381A1 Fusarium resistant cucumber plants |
| 01/04/2012 | EP2401380A2 Pesticidal proteins and methods for their use |
| 01/04/2012 | EP2401379A1 Transgenic plants comprising constructs encoding phosphoenolpyruvate carboxykinase and/or pyruvate ortho phos phate dikinase |
| 01/04/2012 | EP2401378A2 Metabolic engineering of a galactose assimilation pathway in the glycoengineered yeast pichia pastoris |
| 01/04/2012 | EP2401377A1 Expression vector system comprising two selection markers |
| 01/04/2012 | EP2401376A2 Piggybac transposon variants and methods of use |
| 01/04/2012 | EP2401375A1 Improved design of small-interfering rna |
| 01/04/2012 | EP2401374A1 Means and methods for durable inhibition of pathogens |
| 01/04/2012 | EP2401373A1 Signal sequence-independent pix phage display |
| 01/04/2012 | EP2401371A1 Mutant cells having reduced expression of metallopeptidase, suitable for recombinant polypeptide production |
| 01/04/2012 | EP2401370A1 Novel lignin-resistant cellulase enzymes |
| 01/04/2012 | EP2401366A2 Transaminase biocatalysts |
| 01/04/2012 | EP2401357A1 Host cells and methods of use |
| 01/04/2012 | EP2401302A1 Antibodies containing therapeutic tpo/epo mimetic peptides |
| 01/04/2012 | EP2401295A1 Method for producing antibodies |
| 01/04/2012 | EP2401294A1 Method for producing antibodies |
| 01/04/2012 | EP2401293A2 Designer ligands of tgf-beta superfamily |
| 01/04/2012 | EP2401291A1 Plants having enhanced yield-related traits and a method for making the same |
| 01/04/2012 | EP2400984A1 Her2 antibody compositions |
| 01/04/2012 | EP2400980A2 Visfatin therapeutic agents for the treatment of acne and other conditions |
| 01/04/2012 | EP2400969A1 Method for treating pulmonary diseases using rho kinase inhibitor compounds |
| 01/04/2012 | EP2388016A9 Non-viral nucleic acid molecules delivery systems |
| 01/04/2012 | EP2257623B1 Plasmid vector |
| 01/04/2012 | EP2209898B1 Two step cluster deletion and humanisation |
| 01/04/2012 | EP2176409B1 Nucleic acid construct systems capable of diagnosing or treating a cell state |
| 01/04/2012 | EP2162537B1 Use of genetically modified organisms to generate biomass degrading enzymes |
| 01/04/2012 | EP2092065B1 Antisense compounds |
| 01/04/2012 | EP2059587B1 Laccases for pulp bio-bleaching |
| 01/04/2012 | EP2046831B1 Novel multivalent immunoglobulins |
| 01/04/2012 | EP1994142B1 Methods and compositions for the rapid isolation of small rna molecules |
| 01/04/2012 | EP1971683B1 Adenylate cyclase, gene sequence coding for adenylate cyclase, vectors and cells, and the use thereof |
| 01/04/2012 | EP1907582B1 Ect2 as a therapeutic target for esophageal cancer |
| 01/04/2012 | EP1827101B1 Combination of immuno gene therapy and chemotherapy for treatment of cancer and hyperproliferative diseases |
| 01/04/2012 | EP1817413B1 Oligonucleotide ladder assembly and system for generating molecular diversity |
| 01/04/2012 | EP1814596B1 Antisense antiviral compounds and methods for treating filovirus infection |
| 01/04/2012 | EP1805200B1 Neurotransmitter sensors and methods of using the same |
| 01/04/2012 | EP1789564B1 Promoter molecules for use in plants |
| 01/04/2012 | EP1679950B1 Tomatoes having reduced polygalacturonase activity caused by non-transgenic mutations in the polygalacturonase gene |
| 01/04/2012 | EP1624847B1 Compositions and methods for the preparation of human growth hormone glycosylation mutants |
| 01/04/2012 | EP1499709B1 Promoter and plasmid system for genetic engineering |
| 01/04/2012 | EP1453979B1 Multiplex pcr |
| 01/04/2012 | EP1337845B1 Method for analyzing mass spectra |
| 01/04/2012 | EP1331845B1 Barley with reduced ssii activity and starch containing products with a reduced amylopectin content |
| 01/04/2012 | EP1187850B1 Antimicrobial theta defensins and methods of using same |
| 01/04/2012 | EP1080107B1 Novel peptides which represent the epitopes of the human herpes virus type 8 |
| 01/04/2012 | EP1025194B2 Bleaching compositions comprising multiply-substituted protease variants |
| 01/04/2012 | CN1950503B Regulation of environmental stress-tolerance in plants using modified dreb2a gene |
| 01/04/2012 | CN1944460B Alr polypeptide and application thereof |
| 01/04/2012 | CN1896108B Preparation of specific anticoagulation matter and its use |
| 01/04/2012 | CN1839154B Isoforms of elF-5A: senescence-induced elF-5A, wounding-induced elF-5A, growth elF-5A, and DHS |
| 01/04/2012 | CN1798838B Inhibitor proteins of a protease and use thereof |
| 01/04/2012 | CN1740195B Polypeptide gapM1 and its prepn process |
| 01/04/2012 | CN102308000A Plants producing 2n gametes or apomeiotic gametes |
| 01/04/2012 | CN102307999A Polynucleotide comprising sequences of wheat gliadins and use thereof for silencing by rnai |
| 01/04/2012 | CN102307998A Transformation of sugarcane |
| 01/04/2012 | CN102307997A Treatment of sirtuin 1 (SIRT1) related disease by inhibition of natural antisense transcript to SIRT1 |
| 01/04/2012 | CN102307996A Compositions and methods for inhibiting expression of PTP1B genes |
| 01/04/2012 | CN102307995A Transformed soybean plant which stores vaccine, and use thereof |
| 01/04/2012 | CN102307994A Modification of multidomain enzyme for expression in plants |
| 01/04/2012 | CN102307988A Recombinant relastonia eutropha capable of producing polyactic acid or polylatic acid copolymer, and method for producing polyactic acid or polylatic acid copolymer using same |
| 01/04/2012 | CN102307904A Conjugates of neurotensin or neurotensin analogs and uses thereof |
| 01/04/2012 | CN102307896A Fibronectin type III domain based scaffold compositions, methods and uses |